Baseline demographic characteristics of mothers and infants (N = 2,031^b'*'). by Adriana Vázquez-Vázquez (9672972)

Effects of additive FCM in basal diet on growth performance of weaned piglet (n = 10). by Ruiming Xiao (6389546)

Expanding Three-Coordinate Gold(I) Anticancer Agent Chemical Space by Charles E. Greif (21728091)

“…The complexes demonstrated submicromolar cytotoxic activity against human breast cancer cells MDA-MB-231 or MDA-MB-468 with IC₅₀’s in the range of 0.4–5.0 μM. Complex <b>2e</b> shows high potency in vitro and decreases 3D-breast cancer mammosphere viability. …”

Orsay virus infection of the <i>lin-8(n2731</i>) synMuv A mutant induces a Muv phenotype indicative of decreased synMuv B gene activity, and 2 different synMuv B mutants produce 50–100× less Orsay virus RNA. by Ashwin Seetharaman (615458)

First regression: Rate of rise of confirmed cases of COVID-19 in 50 countries, and the associated local meteorological and demographic variables. by Adam Kaplin (10156481)

Lubrication Behavior of Fullerene-Coated Nanoparticles on Rough Surfaces by Guangchao Han (1453198)

K562 cells were treated with 40 nM of miR-214 mimics or a negative mimics control for 24 h, followed by treatment with 50 μM of hemin for 48 h. by Tipparat Penglong (164413)

Virchow’s Triad, including hypercoagulability suggested by decreased fibrinogen in placentas exposed to intrauterine inflammation. by Solange N. Eloundou (6551627)

MRI imaging and analysis, revealing decreased volume and thickness of placentas exposed to intrauterine inflammation. by Solange N. Eloundou (6551627)

Decreasing oxygen saturation with corresponding levels of NLR and D-dimer for understanding the interplay of inflammation. by Narendran Gopalan (110148)

αHT compound 390 does not affect intracellular capsid accumulation or encapsidated HBV RNA levels in HepG2.2.15 cells. by Daniel P. Bradley (10306893)

Subjects:

1466 does not change total yield of capsids during biochemical assembly reactions. by Daniel P. Bradley (10306893)

Subjects:

HPD compounds 1736 and 1740 also suppress accumulation of HBV capsids. by Daniel P. Bradley (10306893)

Subjects:

Compound 390 induces HBV capsid accumulation via an ROS-mediated mechanism. by Daniel P. Bradley (10306893)

Subjects:

HBV RNaseH inhibitors effects on capsid accumulation occur independent of HBV DNA synthesis. by Daniel P. Bradley (10306893)

Subjects:

1466 slows the capsid assembly rate in biochemical Cp149 capsid assembly reactions. by Daniel P. Bradley (10306893)

Subjects:

Differences among the classes of CAMs. by Daniel P. Bradley (10306893)

Subjects:

HBV replication cycle with modeled activity of 1466, a bimodal HBV RNaseH-CAM-I Inhibitor, and other small molecule inhibitors used in this study. by Daniel P. Bradley (10306893)

Subjects:

Compound structures and preferential inhibition of the HBV plus-polarity DNA strand. by Daniel P. Bradley (10306893)

Subjects:

1466 does not induce disassembly of pre-formed HBV capsids in cell lysates. by Daniel P. Bradley (10306893)

Subjects: